Efficacy of vunakizumab in patients with moderate-to-severe plaque psoriasis across diverse disease features: a post hoc analysis of a phase-III trial
Background The efficacy of interleukin-17 inhibitors may be impacted by baseline psoriasis features.Objective This post hoc analysis aimed to explore the efficacy of vunakizumab in patients with moderate-to-severe plaque psoriasis stratified by diverse disease features.Methods This post hoc analysis...
Guardat en:
| Autors principals: | , , , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Taylor & Francis Group
2026-12-01
|
| Col·lecció: | Journal of Dermatological Treatment |
| Matèries: | |
| Accés en línia: | https://www.tandfonline.com/doi/10.1080/09546634.2026.2641340 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|